ArticleFrontiers in oncology2021

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients.

Mei-Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.